-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/colorectal-cancer-screening-june-2016
June 15, 2016 - The pooled event rate from 26 studies in screening populations or generally asymptomatic persons was … The pooled event rate from 22 studies in screening populations or generally asymptomatic persons was … The pooled event rate from 16 studies was 0.74 perforations per 10,000 procedures, with a 95% confidence … The pooled event rate from 10 studies is 1.76 major bleeding events per 10,000 procedures, with a 95%
-
www.uspreventiveservicestaskforce.org/uspstf/document/other-supporting-document19468/tobacco-and-nicotine-use-prevention-in-children-and-adolescents-primary-care-interventions
April 28, 2020 - No significant difference between bupropion and control in experiencing a serious or severe adverse event
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/R3y9LSud52CGL8mG4wvxoT
June 09, 2020 - , 0.89 [95% CI, 0.06 to 13.7]),125 and 1 trial
(n = 287) found no difference in risk of any adverse event
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/unhealthy-alcohol-use-adolescents-adults-behavioral-counseling-interventions
May 16, 2024 - harms at any time point after the screening or intervention began (e.g., death, seizure, cardiovascular event
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/human-immunodeficiency-virus-hiv-infection-screeni
July 05, 2005 - antiretroviral drugs, drug classes, and drug combinations are all associated with specific adverse event … Swiss cohort study of adverse events in clinical practice, 47% of patients reported a clinical adverse event … over 3 y, n
0.006-0.6
0.02-2
0.1-30
NNS H to cause 1 cardiovascular or cerebrovascular event … Specific antiretroviral drugs and combinations are associated with specific adverse event profiles. … ) or death and to cause 1 cardiovascular event (myocardial infarction, invasive cardiovascular procedure
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/human-immunodeficiency-virus-hiv-infection-screening-2005
July 05, 2005 - antiretroviral drugs, drug classes, and drug combinations are all associated with specific adverse event … Swiss cohort study of adverse events in clinical practice, 47% of patients reported a clinical adverse event … over 3 y, n
0.006-0.6
0.02-2
0.1-30
NNS H to cause 1 cardiovascular or cerebrovascular event … Specific antiretroviral drugs and combinations are associated with specific adverse event profiles. … ) or death and to cause 1 cardiovascular event (myocardial infarction, invasive cardiovascular procedure
-
www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/prevention-human-immunodeficiency-virus-hiv-infection-prep
December 13, 2022 - 0.27 to 0.72]) were similar. 15 All trials evaluated daily PrEP, with the exception of one trial of event-driven … This trial found event-driven PrEP was associated with a significantly decreased risk of HIV infection … doses of PrEP per week, so it is uncertain whether this finding would apply to less frequent use of event-driven
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/vitamin-d-deficiency-screening
April 13, 2021 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
Final Recommendation Statement
Vitamin D Deficiency in Adults: Screening
April 13, 2021
Recommendations made by the USPSTF are independent of the U.S. government. They sh…
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-b-virus-infection-screening
December 15, 2020 - differences in the risk of serious adverse events (4 trials; RR, 0.92 [95% CI, 0.45-1.85]), any adverse event … Pegylated interferon was associated with an increased risk of any adverse event compared with lamivudine
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/3khZ9a2mY7eYPVhNY5ZdkC
April 04, 2019 - Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: Clinical Summary
Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: Clinical Summary
Population Adults aged 40 to 70 y who are overweight or obese
Recommendation
Screen for abnormal blood glucose. Offer or refer patients…
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan141/obesity-in-children-and-adolescents-screening
February 12, 2015 - case-control studies with appropriate comparison group; large case-series; large case-series; large event
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan141/obesity-in-children-and-adolescents-screening-june-2017
February 12, 2015 - case-control studies with appropriate comparison group; large case-series; large case-series; large event
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/Z6Rfj-qwfoMbuLp-hBmhzS
May 01, 2021 - Sleep-related QOL
(SAQLI, FOSQ, or QSQ):
17 RCTs (3083)
Cardiovascular events:
8 RCTs (1529)
Mortality: no event … (27 RCTs) or 1
event (2 RCTs) at ≤12 wk; no
significant difference at 24 wk
(1 RCT: 2 vs 2), median
-
www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/latent-tuberculosis-infection-adults
November 22, 2022 - Share to Facebook
Share to Twitter
Share to WhatsApp
Share to E-mail
Print
in progress
Draft Recommendation Statement
Latent Tuberculosis Infection in Adults: Screening
November 22, 2022
Recommendations made by …
-
www.uspreventiveservicestaskforce.org/uspstf/document/published-comments-and-response/aspirin-for-the-prevention-of-cardiovascular-disease-preventive-medication
October 15, 2009 - associated with increased harm in women who were currently smoking (relative risk for major cardiovascular event
-
www.uspreventiveservicestaskforce.org/uspstf/document/published-comments-and-response/aspirin-for-the-prevention-of-cardiovascular-disease-preventive-medication-2009
October 15, 2009 - associated with increased harm in women who were currently smoking (relative risk for major cardiovascular event
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-b-virus-infection-screening-may-2014
June 18, 2014 - difference in the risk for serious adverse events or the number of participants who had any adverse event … in risk for serious adverse events (12 trials; RR, 0.8 [CI, 0.6 to 1.1]; I 2 = 0%) or any adverse event … = 0%), withdrawals due to adverse events (RR, 7.6 [CI, 1.1 to 52.0]; I 2 = 38%), and any adverse event
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-b-virus-infection-screening-nonpregnant-adolescents-adults-may-2014
June 18, 2014 - difference in the risk for serious adverse events or the number of participants who had any adverse event … in risk for serious adverse events (12 trials; RR, 0.8 [CI, 0.6 to 1.1]; I 2 = 0%) or any adverse event … = 0%), withdrawals due to adverse events (RR, 7.6 [CI, 1.1 to 52.0]; I 2 = 38%), and any adverse event
-
www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/current-members/karina-w-davidson-phd-masc
March 01, 2021 - Karina W. Davidson, Ph.D., M.A.Sc.
Chairperson
Karina W. Davidson is senior vice president of research, dean of academic affairs, and head of a new institute focused on health system science, including personalized trials, at the Feinstein Institutes for Medical Research at Northwell Health. She is also a …
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/VNs-WaxpPcsodxCb57gYmn
January 03, 2017 - untitled
Copyright 2017 American Medical Association. All rights reserved.
Screening for Obstructive Sleep Apnea in Adults
US Preventive Services Task Force
Recommendation Statement
US Preventive Services Task Force
T he US Preventive Services Task Force (USPSTF) makes rec-ommendations about the effectiveness of sp…